More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana Inc’s. Dixie Elixir’s Brand Launching Its First THC/CBD Product: Dixie X Synergy

Medical Marijuana Inc’s. Dixie Elixir’s Brand Launching Its First THC/CBD Product: Dixie X Synergy

by adminAdrianRamirez | Apr 16, 2013 | Company News, Press Releases

SAN DIEGO, April 16, 2013 (GLOBE NEWSWIRE) — Medical Marijuana Inc. (OTC:MJNA), a leading hemp industry innovator, announced that its portfolio company, Red Dice Holdings, LLC brand Dixie Elixirs and Edibles, is launching Dixie X Synergy, its first hybrid...

Pre-Market Trading Commentary On High Volume Penny Stocks: (OTC Pink: MJNA), (OTC Pink: OGZPY)

by adminAdrianRamirez | Apr 16, 2013 | Company News, Industry Updates, Media Coverage

New York (April 16th, 2013) – Medical Marijuana, Inc. (OTC Pink: MJNA) announced that its portfolio company, Red Dice Holdings, LLC brand Dixie Elixirs and Edibles, has completed negotiations with The Cashmere Agency, representative for hip-hop and reggae...
Medical Marijuana Inc.’s Dixie Elixirs Brand to Co-Sponsor Premiere of Snoop Lion Movie “Reincarnated” During 4/20 Week

Medical Marijuana Inc.’s Dixie Elixirs Brand to Co-Sponsor Premiere of Snoop Lion Movie “Reincarnated” During 4/20 Week

by adminAdrianRamirez | Apr 15, 2013 | Company News, Press Releases

SAN DIEGO, April 15, 2013 (GLOBE NEWSWIRE) — Medical Marijuana Inc. (OTC:MJNA), a leading hemp industry innovator, announced that its portfolio company, Red Dice Holdings, LLC brand Dixie Elixirs and Edibles, has completed negotiations with The Cashmere Agency,...
Medical Marijuana Inc. Reports Record First Quarter 2013 Revenue and Income

Medical Marijuana Inc. Reports Record First Quarter 2013 Revenue and Income

by adminAdrianRamirez | Apr 11, 2013 | Company News, Kannalife Sciences, Press Releases

SAN DIEGO, April 11, 2013 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC:MJNA), a leading cannabis and hemp industry innovator, today is pleased to pre-announce its fourth quarter earnings. The company earned net income of approximately $5.52 million on gross...

Early Movers: Medical Marijuana Inc, Royale Energy, Wells Fargo & Co, Citigroup Inc

by adminAdrianRamirez | Apr 11, 2013 | Company News, Industry Updates, Media Coverage

NEW YORK, April 11, 2013 – cheapstocks.us, one of the leaders in providing investment alerts on U.S. stocks are announcing Investment Highlights on Medical Marijuana Inc, Royale Energy, Wells Fargo & Co, Citigroup Inc. Medical Marijuana Inc (PINK:MJNA) stock...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.